Strategas believes that corporate lobbying can produce positive benefits through successful policy outcomes. The operational and competitive advantages gained often lead to tangible improvement in company fundamentals.
The Fund combines Strategas’ proprietary super-cyclical “lobbying intensity” analytical framework with the Firm’s recommended asset allocation.
The Fund uses publicly available lobbying data to consider investments in both domestic and international companies set to benefit from periods of intense lobbying of the U.S. federal government.
A global equity portfolio leveraged to successful public policy outcomes with tactical tilts toward the most favorable equity sleeves, i.e. domestic vs. international, large vs. mid & small-cap, etc.
|Total Expense Ratio||0.65%|
|30-Day Median Bid-Ask Spread||0.26%|
|Cumulative||1 Month||3 Month||6 Month||1 Year||Since Inception|
|Cumulative||1 Month||3 Month||YTD||1 Year||Since Inception|
The performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment returns and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance data for the most recent month-end is available above. For most recent data please call (855) 457-3637.
NAV: The dollar value of a single share, based on the value of the underlying assets of the fund minus its liabilities, divided by the number of shares outstanding. Calculated at the end of each business day.
Market Price: The current price at which shares are bought and sold. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time.
|Calendar Year 2022||4th Quarter of 2022|
|Days Traded at Premium||151||32|
|Days Traded at Discount||60||16|
The above frequency distribution chart presents information about the difference between the daily market price for shares of the Fund and the Fund's reported Net Asset Value. The amount that the Fund's market price is above the reported NAV is called the premium. The amount that the Fund's market price is below the reported NAV is called the discount. The market price is determined using the midpoint between the highest bid and the lowest offer on the listing exchange, as of the time that the Fund's NAV is calculated (usually 4:00 p.m. EST). The vertical axis of the chart shows the premium or discount expressed as a percentage. The horizontal axis indicates the trading day with each bar representing a specific day.
|4523||EISAI CO LTD||5,100||1.87%|
|NZYMB||NOVOZYMES A/S-B SHARES||5,969||1.87%|
|SMIN||SMITHS GROUP PLC||17,907||1.81%|
Holdings are subject to change without notice.
Strategas Asset Management, LLC
(855) 457-3637 toll-free
52 Vanderbilt Avenue, 19th Floor
New York, New York 10017
Carefully consider the Fund’s investment objectives, risk, and charges and expenses. This and other information can be found in the Fund’s summary or full prospectus which can be obtained by calling (855) 457-3637 or by visiting strategasetfs.com. Please read the prospectus, carefully before investing.
The Fund is new and has a limited operating history.
An investment in the Fund involves risk, including possible loss of principal. In addition to the normal risks associated with investing, the Fund is subject to lobbying focused investment risk. The adviser’s investment process utilizes lobbying intensity as the primary input when selecting investments for the Fund’s portfolio and does not consider an investment’s traditional financial metrics. The Fund may underperform other funds that select investments utilizing more traditional investment metrics. The Fund may also focus its investments in a particular country or geographic region outside the U.S. and may be more susceptible to economic, political, regulatory or other events or conditions affecting issuers and countries within that country or geographic regions well as risks of increased volatility and lower trading volume. The Fund may be more heavily invested in particular sectors and may be especially sensitive to factors and economic risks that specifically affect those sectors.
Strategas Asset Management, LLC serves as the investment advisor of the Fund and Vident Investment Advisory, LLC serves as a sub advisor to the Fund. The Fund is distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Strategas Asset Management, LLC or any of its affiliates.
Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Brokerage commissions will reduce returns.
30-Day Median Bid-Ask Spread
The median bid-ask spread is a calculation of Fund's median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, computed by: identifying the Fund’s national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values.